Endotoxemia in Healthy Subjects as a Human Model of Inflammation
- 1 January 2002
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Antiinflammatory Cytokine Responses during Clinical Sepsis and Experimental Endotoxemia: Sequential Measurements of Plasma Soluble Interleukin (IL)-1 Receptor Type II, IL-10, and IL-13The Journal of Infectious Diseases, 1997
- Inhibition of Endotoxin-Induced Cytokine Release and Neutrophil Activation in Humans by Use of Recombinant Bactericidal/Permeability-Increasing ProteinThe Journal of Infectious Diseases, 1995
- Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentrations in manJournal of Clinical Endocrinology & Metabolism, 1995
- Effects of endotoxin on leucine and glucose kinetics in man: contribution of prostaglandin E2 assessed by a cyclooxygenase inhibitorJournal of Clinical Endocrinology & Metabolism, 1993
- Total Parenteral Nutrition and Bowel Rest Modify the Metabolic Response to Endotoxin in HumansAnnals of Surgery, 1989
- The Cardiovascular Response of Normal Humans to the Administration of EndotoxinNew England Journal of Medicine, 1989
- Peripheral Blood Leukocyte Kinetics Following In Vivo Lipopolysaccharide (LPS) Administration to Normal Human SubjectsAnnals of Surgery, 1989
- Promotion and Subsequent Inhibition of Plasminogen Activation after Administration of Intravenous Endotoxin to Normal SubjectsNew England Journal of Medicine, 1989
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988
- Nonspecific enhancers of resistance in manThe Journal of Pediatrics, 1975